Mississippi Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 15 (75% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 15,617
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 72.64%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 4,222
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 67.06%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 26.56% 32.26%
White, Hispanic/Latino Patients 0.74% 1.21%
Black/African American, Non-Hispanic/Latino Patients 66.48% 60.68%
Black/African American, Hispanic/Latino Patients 0.24% 0.33%
Asian Patients3 0.40% 0.47%
American Indian/Alaska Native Patients3 0.35% 0.31%
Native Hawaiian/Other Pacific Islander Patients3 0.20% 0.19%
Patients with More Than One Race3 1.40% 1.37%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.72% 1.11%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.66% 0.81%
Unreported/Refused to Report Race and Ethnicity 1.24% 1.26%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 691
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 83.49%
COVID-19 Immunization Series Completed 592
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 83.42%
COVID-19 Immunization Series Additional 2,073
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 82.28%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 15.63% 16.22% 17.17%
White, Hispanic/Latino Patients 0.72% 0.68% 0.72%
Black/African American, Non-Hispanic/Latino Patients 72.07% 79.56% 67.97%
Black/African American, Hispanic/Latino Patients 0.58% 0.17% 0.14%
Asian Patients3 0.58% 0.17% 0.14%
American Indian/Alaska Native Patients3 0.43% 0.17% 9.89%
Native Hawaiian/Other Pacific Islander Patients3 0.29% 0.51% 0.53%
Patients with More Than One Race3 3.33% 0.34% 0.19%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.01% 0.00% 0.14%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.76% 1.35% 1.93%
Unreported/Refused to Report Race and Ethnicity 1.59% 0.84% 1.16%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 26.67%
1 to 24 Hours 33.33%
More Than 24 Hours 40.00%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 13.33%
Staffing to administer the vaccine 60.00%
Vaccine confidence 20.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 0.00%
None 26.67%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 6.67%
Average Percent of Health Center Visits Conducted Virtually 9.33%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 46.67%
Number of Mobile Van Sites 8
Number of Pop-up Clinics 4
Number of School-Based Vaccination Sites 6
Number of Family Vaccination Clinics 7

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 26.67%
Refer patients to another organization that provides monoclonal antibody therapies 40.00%
None 40.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 20.00%
Therapy administration/onsite logistics 26.67%
Other 0.00%
None 60.00%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 0
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 0

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients -
Provide to General Public Who Came to the Health Center -
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) -
Provide at Other Community Events -
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) -
Other -

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 0
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 -

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients -
White, Hispanic/Latino Patients -
Black/African American, Non-Hispanic/Latino Patients -
Black/African American, Hispanic/Latino Patients -
Asian Patients3 -
American Indian/Alaska Native Patients3 -
Native Hawaiian/Other Pacific Islander Patients3 -
Patients with More Than One Race3 -
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Unreported/Refused to Report Race and Ethnicity -

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers -
Patients Experiencing Homelessness -
Patients Who Are Residents of Public Housing -
Patients with Limited English Proficiency -
Children Under 18 Years of Age -

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022